Highest ROE in Healthcare
The most profitable companies in the Healthcare sector by return on equity.
As of Sep 11, 2026
| # | Company | Industry | Price | Mkt Cap | P/E | P/B | ROE | Net Margin | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MTD | Medical - Diagnostics & Research | $1,280.58 | $25.66B | 29.52 | 2000.97 | 6778.4% | 21.6% | 4.0% | — |
| 2 | HALO | Biological Products, (No Diagnostic Substances) | $107.00 | $12.14B | 38.32 | 84.60 | 220.8% | 22.7% | 37.6% | — |
| 3 | AMRX | Pharmaceutical Preparations | $16.87 | $5.39B | 74.77 | 163.14 | 218.2% | 2.4% | 8.0% | — |
| 4 | RIGL | Biotechnology | $47.28 | $883.18M | 2.41 | 2.08 | 86.3% | 124.7% | 64.1% | — |
| 5 | ZTS | Drug Manufacturers - Specialty & Generic | $72.86 | $30.11B | 11.26 | 9.56 | 84.9% | 28.2% | 2.3% | 2.79% |
| 6 | AVAH | Medical - Care Facilities | $13.86 | $3.02B | 13.44 | 10.53 | 78.3% | 9.2% | 20.2% | — |
| 7 | GILD | Biological Products, (No Diagnostic Substances) | $144.81 | $179.56B | 21.10 | 15.18 | 71.9% | 28.9% | 2.4% | 2.18% |
| 8 | COR | Medical - Distribution | $320.95 | $61.25B | 39.41 | 20.07 | 50.9% | 0.5% | 9.3% | 0.69% |
| 9 | THC | Medical - Care Facilities | $263.46 | $21.21B | 8.96 | 4.55 | 50.8% | 11.1% | 3.1% | — |
| 10 | AUPH | Pharmaceutical Preparations | $16.11 | $2.14B | 7.46 | 3.49 | 46.7% | 101.5% | 20.4% | — |
| 11 | EXEL | Biological Products, (No Diagnostic Substances) | $57.43 | $14.23B | 18.18 | 7.72 | 42.4% | 33.7% | 7.0% | — |
| 12 | ZVRA | Biotechnology | $12.06 | $716.17M | 8.60 | 3.29 | 38.2% | 78.2% | 350.9% | — |
| 13 | TBPH | Biotechnology | $17.02 | $883.66M | 8.34 | 3.05 | 36.6% | 98.5% | 66.9% | — |
| 14 | CRMD | Pharmaceutical Preparations | $7.96 | $620.44M | 3.81 | 1.35 | 35.4% | 52.3% | 617.0% | — |
| 15 | CHE | Medical - Care Facilities | $514.40 | $6.72B | 25.35 | 8.10 | 31.9% | 10.5% | 4.1% | 0.43% |
| 16 | DXCM | Medical - Devices | $84.51 | $31.89B | 38.13 | 12.17 | 31.9% | 17.9% | 15.6% | — |
| 17 | BMY | Pharmaceutical Preparations | $63.75 | $130.22B | 18.46 | 5.83 | 31.6% | 14.6% | -0.2% | 3.91% |
| 18 | NVS | Pharmaceutical Preparations | $137.48 | $262.33B | 18.76 | 5.69 | 30.3% | — | — | — |
| 19 | ACAD | Biotechnology | $27.74 | $4.78B | 12.22 | 3.66 | 29.9% | 36.5% | 11.9% | — |
| 20 | PAHC | Pharmaceutical Preparations | $36.58 | $2.52B | 25.28 | 6.54 | 25.9% | 6.6% | 17.1% | 1.31% |
| 21 | ALNY | Pharmaceutical Preparations | $247.51 | $33.12B | 105.56 | 24.46 | 23.2% | 8.4% | 65.2% | — |
| 22 | RMD | Surgical & Medical Instruments & Apparatus | $219.58 | $31.67B | 20.79 | 4.81 | 23.1% | 26.9% | 9.9% | 1.09% |
| 23 | MDXG | Biotechnology | $4.60 | $670.50M | 13.80 | 3.10 | 22.5% | 11.6% | 20.0% | — |
| 24 | INVA | Pharmaceutical Preparations | $20.62 | $1.49B | 5.49 | 1.21 | 22.0% | 65.9% | 14.7% | — |
| 25 | EHC | Services-Hospitals | $121.04 | $11.94B | 21.09 | 4.60 | 21.8% | 9.5% | 10.5% | 0.59% |
Dated archive
Permanent snapshots of this list, frozen each day.
- 2026-09-11 25 stocks
- 2026-09-09 25 stocks
- 2026-09-07 25 stocks
- 2026-09-05 25 stocks
- 2026-09-03 25 stocks
- 2026-09-01 25 stocks
- 2026-08-30 25 stocks
- 2026-08-28 25 stocks
- 2026-08-26 25 stocks
- 2026-08-24 25 stocks
- 2026-08-22 25 stocks
- 2026-08-20 25 stocks
- 2026-08-18 25 stocks
- 2026-08-16 25 stocks
- 2026-08-14 25 stocks
- 2026-08-12 25 stocks
- 2026-08-10 25 stocks
- 2026-08-08 25 stocks
- 2026-08-06 25 stocks
- 2026-08-04 25 stocks
- 2026-08-02 25 stocks
- 2026-07-31 25 stocks
- 2026-07-29 25 stocks
- 2026-07-27 25 stocks
- 2026-07-25 25 stocks
- 2026-07-23 25 stocks
- 2026-07-21 25 stocks
- 2026-07-19 25 stocks
- 2026-07-17 25 stocks
- 2026-07-15 25 stocks